Abstract
Purpose
Obstructive sleep apnea syndrome (OSAS) has been recognized as an important risk factor for cardiovascular morbidity and mortality. However, the underlying mechanisms are poorly understood. Present study aimed to investigate the role of NF-κB-dependent inflammation pathways in pathophysiological responses of cardiovascular system in OSAS.
Methods
Thirty male specific pathogen-free (SPF) Sprague-Dawley rats were randomly assigned to normoxia (N) group, continual hypoxia (CH) group, and intermittent hypoxia (IH) group (n = 10) and were exposed to N (21 % O2), CH (8 % O2), or IH (6–11 % O2 for 10 s and 21 % O2 for 80 s in every 90 s) for 8 h/day for 35 days. The hemodynamic and pathomorphologic effects of IH and CH exposure were investigated as well as the expression of NF-κB-dependent inflammation factors.
Results
Chronic IH or CH significantly increased mean pulmonary arterial pressure (mPAP) in rats, while no significant changes occurred in mean carotid arterial pressure (mCAP). The ratio of right ventricle (RV) to left ventricle (LV) + septum (S) was significantly increased by both IH and CH, suggesting RV hypertrophy was induced by IH or CH. Elastic fiber staining showed an irregular pattern of elastic fiber distribution after hypoxia, and aortic tunica media thickness was increased. Both chronic IH and CH upregulated the expressions of transcription factor NF-κB and related pro-inflammatory cytokines and adhesion molecules.
Conclusions
The current study expands our understanding that both IH and CH could activate the expression of NF-κB and related inflammatory factors as well as cause pathophysiologic damage to the cardiovascular system in OSAS. All these results provide further support to an emerging hypothesis that activation of NF-κB-dependent inflammation may play a central role in the pathophysiology of cardiovascular dysfunction in OSAS.
Similar content being viewed by others
References
Mbata G, Chukwuka J (2013) Obstructive sleep apnea hypopnea syndrome. Arch Med Health Sci 2(1):74–77
McNicholas W, Bonsignore M (2007) Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29(1):156–178
Foster GE, Poulin MJ, Hanly PJ (2007) Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea. Exp Physiol 92(1):51–65
Campen M, Shimoda L, O’Donnell C (2005) Acute and chronic cardiovascular effects of intermittent hypoxia in C57BL/6J mice. J Appl Physiol 99(5):2028–2035
Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112(17):2660–2667
Fletcher EC (2001) Physiological consequences of intermittent hypoxia: systemic blood pressure. J Appl Physiol 90(4):1600–1605
de Frutos S, Duling L, Alò D, Berry T, Jackson-Weaver O, Walker M, Kanagy N, Bosc LG (2008) NFATc3 is required for intermittent hypoxia-induced hypertension. Am J Physiol Heart Circ 294(5):H2382–H2390
Arnaud C, Beguin PC, Lantuejoul S, Pepin J-L, Guillermet C, Pelli G, Burger F, Buatois V, Ribuot C, Baguet J-P (2011) The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition. Am J Respir Crit Care Med 184(6):724–731
Greenberg H, Ye X, Wilson D, Htoo AK, Hendersen T, Liu SF (2006) Chronic intermittent hypoxia activates nuclear factor-κB in cardiovascular tissues in vivo. Biochem Biophys Res Commun 343(2):591–596
Ryan S, Taylor C, McNicholas W (2009) Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 64(7):631–636
Bhattacharjee R, Kim J, Kheirandish‐Gozal L, Gozal D (2011) Obesity and obstructive sleep apnea syndrome in children: a tale of inflammatory cascades. Pediatr Pulmonol 46(4):313–323
Kim J, Hakim F, Kheirandish-Gozal L, Gozal D (2011) Inflammatory pathways in children with insufficient or disordered sleep. Respir Physiol Neurobiol 178(3):465–474
Garvey J, Taylor C, McNicholas W (2009) Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 33(5):1195–1205
Htoo AK, Greenberg H, Tongia S, Chen G, Henderson T, Wilson D, Liu SF (2006) Activation of nuclear factor κB in obstructive sleep apnea: a pathway leading to systemic inflammation. Sleep Breathing 10(1):43–50
Minoguchi K, Tazaki T, Yokoe T, Minoguchi H, Watanabe Y, Yamamoto M, Adachi M (2004) Elevated production of tumor necrosis factor-α by monocytes in patients with obstructive sleep apnea syndrome. Chest J 126(5):1473–1479
Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y (2003) Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94(1):179–184
Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, Remuzzi G (1998) Protein overload stimulates RANTES production by proximal tubular cells depending on NF-κB activation. Kidney Int 53(6):1608–1615
Zuckerbraun BS, Shiva S, Ifedigbo E, Mathier MA, Mollen KP, Rao J, Bauer PM, Choi JJ, Curtis E, Choi AM (2010) Nitrite potently inhibits hypoxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidoreductase–dependent nitric oxide generation. Circulation 121(1):98–109
Calhoun DA, Harding SM (2010) Sleep and hypertension. Chest J 138(2):434–443
Gong Y, Fan X, Wu X, Hu L, Tang C, Pang Y, Qi Y (2007) Changes of intermedin/adrenomedullin 2 and its receptors in the right ventricle of rats with chronic hypoxic pulmonary hypertension. Sheng Li Xue Bao Acta Physiologica Sinica 59(2):210–214
Peng P, Ly H, Li J, Fan R, Zhang SM, Wang YM, Hu YZ, Sun X, Kaye AD, Pei JM (2009) Distribution of κ-opioid receptor in the pulmonary artery and its changes during hypoxia. Anat Rec 292(7):1062–1067
Li J, Zhang P, Zhang Q-y, Zhang S-m, Guo H-t, Bi H, Wang Y-m, Sun X, Liu J-c, Cheng L (2009) Effects of U50, 488H on hypoxia pulmonary hypertension and its underlying mechanism. Vasc Pharmacol 51(2):72–77
Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi-Filho G (2005) Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172(5):613–618
Bagai K (2010) Obstructive sleep apnea, stroke, and cardiovascular diseases. Neurologist 16(6):329–339
Almendros I, Farré R, Torres M, Bonsignore MR, Dalmases M, Ramírez J, Navajas D, Montserrat JM (2011) Early and mid-term effects of obstructive apneas in myocardial injury and inflammation. Sleep Med 12(10):1037–1040
Yamauchi M, Tamaki S, Tomoda K, Yoshikawa M, Fukuoka A, Makinodan K, Koyama N, Suzuki T, Kimura H (2006) Evidence for activation of nuclear factor kappaB in obstructive sleep apnea. Sleep Breathing 10(4):189–193
Williams A, Scharf SM (2007) Obstructive sleep apnea, cardiovascular disease, and inflammation—is NF-κB the key? Sleep Breathing 11(2):69–76
Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342(12):836–843
Nakakuki T, Ito M, Iwasaki H, Kureishi Y, Okamoto R, Moriki N, Kongo M, Kato S, Yamada N, Isaka N (2005) Rho/Rho-kinase pathway contributes to C-reactive protein–induced plasminogen activator inhibitor-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol 25(10):2088–2093
Monaco C, Paleolog E (2004) Nuclear factor κB: a potential therapeutic target in atherosclerosis and thrombosis. Cardiovasc Res 61(4):671–682
Hayashi M, Fujimoto K, Urushibata K, Takamizawa A, Kinoshita O, Kubo K (2006) Hypoxia-sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome. Respirology 11(1):24–31
Chin K, Nakamura T, Shimizu K, Mishima M, Nakamura T, Miyasaka M, Ohi M (2000) Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 109(7):562–567
Quercioli A, Mach F, Montecucco F (2010) Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS). Sleep Breathing 14(3):261–269
Nelson PJ, Kim H, Manning W, Goralski T, Krensky A (1993) Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol 151(5):2601–2612
Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Matsunaga K, Fukushima J, Kawamoto S, Ishigatsubo Y, Okubo T (1994) NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 153(5):2052–2063
Lloyd CM, Minto AW, Dorf ME, Proudfoot A, Wells TN, Salant DJ, Gutierrez-Ramos J-C (1997) RANTES and monocyte chemoattractant protein–1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 185(7):1371–1380
Koh SJ, Kim JY, Hyun YJ, Park SH, Chae JS, Park S, Kim J-S, Youn JC, Jang Y, Lee JH (2009) Association of serum RANTES concentrations with established cardiovascular risk markers in middle-aged subjects. Int J Cardiol 132(1):102–108
Borel J-C, Roux-Lombard P, Tamisier R, Arnaud C, Monneret D, Arnol N, Baguet J-P, Levy P, Pepin J-L (2009) Endothelial dysfunction and specific inflammation in obesity hypoventilation syndrome. PLoS One 4(8):e6733
Feng J, Wu Q, Zhang D, Chen B (2012) Hippocampal impairments are associated with intermittent hypoxia of obstructive sleep apnea. Chin Med J 125(4):696–701
Wu Q, Wang H-Y, Li J, Zhou P, Wang Q-L, Zhao L, Fan R, Wang Y-M, Xu X-Z, Yi D-H (2013) κ-opioid receptor stimulation improves endothelial function in hypoxic pulmonary hypertension. PLoS One 8(5):e60850
Acknowledgments
This work was supported by the Wenzhou Technology Project Foundation of China (No. Y20090125). The authors want to thank the teachers at the Department of Animal Experiment and Path Physiology for expert technical assistance, and the teachers and students who had participated in this study.
Conflict of interest
All coauthors certify that they have no affiliations with or involvement in any organization or entity with any financial interest, or non-financial interest in the subject matter or materials discussed in this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xu, XM., Yao, D., Cai, XD. et al. Effect of chronic continual- and intermittent hypoxia-induced systemic inflammation on the cardiovascular system in rats. Sleep Breath 19, 677–684 (2015). https://doi.org/10.1007/s11325-014-1075-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-014-1075-9